Skip to content

Clinical trials

Phase 3 Leukemia trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 3 Country / region: Switzerland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20022
20061
20071
20101
20121
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group6
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals2
University Hospital Schleswig-Holstein2
Ariad Pharmaceuticals1
Daiichi Sankyo1
Heidelberg University1
III. Medizinische Klinik Mannheim1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia18
Leukemia, Myelogenous, Chronic, BCR-ABL Positive5
Myelodysplastic Syndromes4
Myeloproliferative Disorders4
Anemia, Refractory3
Anemia, Refractory, with Excess of Blasts3
Leukemia, Myeloid, Acute3
Leukemia, Myeloid, Chronic-Phase3
Leukemia, Myelomonocytic, Chronic3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.